Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
clinical trials
fda
life sciences
national blog main
ulcerative colitis
4
×
investing
san francisco blog main
san francisco top stories
biotech ipos
boston top stories
clostridium difficile
deals
inflammatory bowel disease
medical foods
microbiome
new york blog main
new york top stories
startups
type 2 diabetes
whole biome
acute myeloid leukemia
agtechfood
alx oncology
ame cloud ventures
american diabetes association
antibodies
autoimmune diseases
berkeley lights
biologic drugs
boston
boulder/denver
boulder/denver blog main
boulder/denver top stories
cancer drugs
cancer immunotherapy
cd47
chronic kidney disease
colleen cutcliffe
What
days
ipo
raised
arrival
available
babies
balance
biome
biotech
birth
blood
born
breastfeed
brings
companies
company
developing
diabetes
disorders
drug
dyne
dyne’s
eyes
food
genetic
giving
gut
hasn’t
healthy
hormone
include
industry
instructed
intended
ipos
lands
launch
leads
levels
life
Language
unset
Current search:
" ulcerative colitis "
×
@xconomy.com
4 months ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
6 months ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
1 year ago
PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome
@xconomy.com
1 year ago
With $35M, Whole Biome Eyes 2020 Launch of Medical Food for Diabetes
